You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cyclophosphamid

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial (Cyclophosphamid, ATG)

Not yet recruiting
  • Hematologic Malignancy
  • Cyclophosphamid
  • ATG
  • (no location specified)
Oct 29, 2023

Glomerulonephritis Rapidly Progressive Trial (ALE.F02, Rituximab, GlucoCorticoid)

Not yet recruiting
  • Glomerulonephritis Rapidly Progressive
  • ALE.F02
  • +5 more
  • (no location specified)
Sep 14, 2023

AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • CD33/CLL1 dual CAR-NK cell
  • +5 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 4, 2023

AML, Adult Trial in Hangzhou (QN-030a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Dec 29, 2022

AML, Adult Trial in Tianjin (QN-023a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 3, 2022

Minimal Residual Disease Trial in Tianjin (QN-030a, Cyclophosphamid, Fludarabine)

Recruiting
  • Minimal Residual Disease
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 3, 2022

AML, Adult Trial in Hangzhou (QN-023a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Dec 29, 2022

Early Luminal Breast Cancer and Pancreatic Cancer Patients

Recruiting
  • Breast Cancer
  • Pancreas Cancer
  • Moscow, Not Required, Russian Federation
    Moscow Clinical Scientific Center named after AS Loginov
Oct 12, 2022

Germ Cell Tumor, Nonseminomatous Germ Cell Tumor Trial in Chapel Hill (ATLCAR.CD30 Cells, Cyclophosphamid, Fludarabine)

Recruiting
  • Germ Cell Tumor
  • Nonseminomatous Germ Cell Tumor
  • ATLCAR.CD30 Cells
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 13, 2022

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

B-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Hangzhou (QN-019a, Rituximab, Cyclophosphamid)

Recruiting
  • B-cell Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical College of Zhejiang Uni
May 17, 2022

Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)

Recruiting
  • Myeloid Leukemia, Acute
  • +3 more
  • Bendamustine Hydrochloride
  • Cyclophosphamid
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
Apr 4, 2022

Relapsed or Refractory Multiple Myeloma Trial in Hangzhou (anti-BCMA CAR-T, Cyclophosphamid, Fludarabine)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • anti-BCMA CAR-T
  • +2 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Apr 4, 2021

Metastatic Ovarian Cancer, Metastatic Fallopian Tube Cancer, Peritoneal Cancer Trial in Herlev (Ipilimumab, Cyclophosphamid,

Recruiting
  • Metastatic Ovarian Cancer
  • +2 more
  • Herlev, Denmark
    National Center for Cancer Immune Therapy (CCIT-DK)
May 7, 2021

HER2-negative Breast Cancer, Neoadjuvant Chemo Trial in Hangzhou (Epirubicin, Cyclophosphamid, Docetaxel)

Recruiting
  • HER2-negative Breast Cancer
  • Neoadjuvant Chemotherapy
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 9, 2021

Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +9 more
  • Antwerp, Belgium
  • +9 more
Oct 5, 2021

Breast Cancer Trial in Munich (Docetaxel, Trastuzumab, Bevacizumab)

Terminated
  • Breast Cancer
  • Munich, Bavaria, Germany
    Breast Centre, University of Munich, LMU
Aug 9, 2018